2025 Compounding Labelling 
Pharmaceutical Technology
JUNE 26, 2025
Fi Forrest June 26, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Credit: Shutterstock AI is revolutionizing drug discovery with its ability to analyze vast datasets. AI models can predict molecular interactions and assist in designing novel compounds tailored to specific therapeutic goals.
The Thyroid Pharmacist
NOVEMBER 29, 2023
This is because I had learned about various adulterants found in supplements, how some supplement manufacturers don’t actually put the products that are on the label in the bottle, or that the dosages listed on the label may be completely different from what’s in the products. We have 270 expiring in March 2025.)
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmacy mentor
MAY 30, 2025
Mounjaro was approved by the FDA in 2022, and by mid-2023 it was already widely used off-label for weight loss in the US. It’s currently in late-stage trials and could receive FDA approval in 2025, with European and UK authorisation likely to follow soon after.
The Thyroid Pharmacist
MAY 15, 2025
coli bacteria from adhering to the walls of the urinary tract, thanks to compounds called proanthocyanidins. [9] Accessed May 7, 2025. Accessed May 8, 2025. Published 2025 Feb 26. Cranberry juice Yes, thats right good old cranberry juice! Cranberry juice may help prevent UTIs by preventing E. Ther Adv Urol. Nature News.
Quality Matters
MARCH 1, 2024
USP has a long-standing history of healthcare standards including those for compounding preparations that are tailored to meet the unique needs of patients who may not otherwise have access to their medications. In the meantime, USP encourages interested parties to reach out for more information as USP approaches its new 2025-2030 cycle.
PharmaTech
JUNE 23, 2025
Thakar Varanya Chaiyaperm View All News Article Bulk drug calculations for different types of active moieties and drugs require different calculations and labeling. Calculations provide the amount of drug specified in the medication order needed for compounding; it is the objective of the medication order. Pluta Nishant B.
Pharmacy Times
JUNE 23, 2025
1 Image credit: Cynthia | stock.adobe.com The discussion featured Vivian Fonseca, MD, of the Tulane University School of Medicine, who presented an overview of tirzepatide based on the FDA-approved label and clinical guidelines. Presented: 85th Scientific Sessions of the American Diabetes Association; June 23, 2025; Chicago, Illinois.
Expert insights. Personalized for you.
69 
Let's personalize your content